vs
Side-by-side financial comparison of Azenta, Inc. (AZTA) and Forestar Group Inc. (FOR). Click either name above to swap in a different company.
Forestar Group Inc. is the larger business by last-quarter revenue ($273.0M vs $148.6M, roughly 1.8× Azenta, Inc.). Forestar Group Inc. runs the higher net margin — 5.6% vs -10.4%, a 16.0% gap on every dollar of revenue. On growth, Forestar Group Inc. posted the faster year-over-year revenue change (9.0% vs 0.8%). Azenta, Inc. produced more free cash flow last quarter ($14.7M vs $-157.1M). Over the past eight quarters, Azenta, Inc.'s revenue compounded faster (4.4% CAGR vs -9.6%).
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
Forestar Group Inc. is a residential lot development company based in Arlington, Texas. The company has operations in 51 markets in 21 states and delivered 11,518 residential lots during the twelve-month period ended December 31, 2020. The company is publicly traded on the New York Stock Exchange and in October 2017 became a majority-owned subsidiary of D.R. Horton, Inc., the largest homebuilder by volume in the United States since 2002. The company primarily acquires entitled real estate and...
AZTA vs FOR — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $148.6M | $273.0M |
| Net Profit | $-15.4M | $15.4M |
| Gross Margin | 42.9% | 20.1% |
| Operating Margin | -4.9% | 7.6% |
| Net Margin | -10.4% | 5.6% |
| Revenue YoY | 0.8% | 9.0% |
| Net Profit YoY | -15.7% | -6.7% |
| EPS (diluted) | $-0.34 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.6M | $273.0M | ||
| Q3 25 | $159.2M | $670.5M | ||
| Q2 25 | $143.9M | $390.5M | ||
| Q1 25 | $143.3M | $351.0M | ||
| Q4 24 | $147.4M | $250.4M | ||
| Q3 24 | $150.6M | $551.3M | ||
| Q2 24 | $144.3M | $318.4M | ||
| Q1 24 | $136.4M | $333.8M |
| Q4 25 | $-15.4M | $15.4M | ||
| Q3 25 | $50.9M | $86.9M | ||
| Q2 25 | $-48.0M | $32.9M | ||
| Q1 25 | $-47.7M | $31.6M | ||
| Q4 24 | $-11.0M | $16.5M | ||
| Q3 24 | $-6.6M | $81.5M | ||
| Q2 24 | $-6.6M | $38.7M | ||
| Q1 24 | $-137.4M | $45.0M |
| Q4 25 | 42.9% | 20.1% | ||
| Q3 25 | 45.4% | 22.3% | ||
| Q2 25 | 46.2% | 20.4% | ||
| Q1 25 | 43.8% | 22.6% | ||
| Q4 24 | 46.7% | 22.0% | ||
| Q3 24 | 45.5% | 23.9% | ||
| Q2 24 | 44.8% | 22.5% | ||
| Q1 24 | 43.8% | 24.9% |
| Q4 25 | -4.9% | 7.6% | ||
| Q3 25 | 1.2% | 16.9% | ||
| Q2 25 | -1.3% | 11.2% | ||
| Q1 25 | -12.7% | 11.6% | ||
| Q4 24 | -5.9% | 8.7% | ||
| Q3 24 | -3.1% | 19.7% | ||
| Q2 24 | -4.9% | 16.2% | ||
| Q1 24 | -18.1% | 17.6% |
| Q4 25 | -10.4% | 5.6% | ||
| Q3 25 | 32.0% | 13.0% | ||
| Q2 25 | -33.4% | 8.4% | ||
| Q1 25 | -33.3% | 9.0% | ||
| Q4 24 | -7.5% | 6.6% | ||
| Q3 24 | -4.4% | 14.8% | ||
| Q2 24 | -4.5% | 12.2% | ||
| Q1 24 | -100.8% | 13.5% |
| Q4 25 | $-0.34 | $0.30 | ||
| Q3 25 | $1.12 | $1.70 | ||
| Q2 25 | $-1.05 | $0.65 | ||
| Q1 25 | $-1.04 | $0.62 | ||
| Q4 24 | $-0.25 | $0.32 | ||
| Q3 24 | $-0.25 | $1.59 | ||
| Q2 24 | $-0.12 | $0.76 | ||
| Q1 24 | $-2.48 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $336.6M | $211.7M |
| Total DebtLower is stronger | — | $793.2M |
| Stockholders' EquityBook value | $1.7B | $1.8B |
| Total Assets | $2.1B | $3.2B |
| Debt / EquityLower = less leverage | — | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $336.6M | $211.7M | ||
| Q3 25 | $279.8M | $379.2M | ||
| Q2 25 | $270.0M | $189.2M | ||
| Q1 25 | $253.6M | $174.3M | ||
| Q4 24 | $377.5M | $132.0M | ||
| Q3 24 | $280.0M | $481.2M | ||
| Q2 24 | $336.5M | $359.2M | ||
| Q1 24 | $353.5M | $416.2M |
| Q4 25 | — | $793.2M | ||
| Q3 25 | — | $802.7M | ||
| Q2 25 | — | $872.8M | ||
| Q1 25 | — | $872.5M | ||
| Q4 24 | — | $806.8M | ||
| Q3 24 | — | $706.4M | ||
| Q2 24 | — | $706.1M | ||
| Q1 24 | — | $705.7M |
| Q4 25 | $1.7B | $1.8B | ||
| Q3 25 | $1.7B | $1.8B | ||
| Q2 25 | $1.7B | $1.7B | ||
| Q1 25 | $1.7B | $1.6B | ||
| Q4 24 | $1.7B | $1.6B | ||
| Q3 24 | $1.8B | $1.6B | ||
| Q2 24 | $2.0B | $1.5B | ||
| Q1 24 | $2.2B | $1.5B |
| Q4 25 | $2.1B | $3.2B | ||
| Q3 25 | $2.1B | $3.1B | ||
| Q2 25 | $2.0B | $3.1B | ||
| Q1 25 | $2.0B | $3.0B | ||
| Q4 24 | $2.0B | $3.0B | ||
| Q3 24 | $2.1B | $2.8B | ||
| Q2 24 | $2.3B | $2.7B | ||
| Q1 24 | $2.6B | $2.6B |
| Q4 25 | — | 0.44× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.48× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.8M | $-157.0M |
| Free Cash FlowOCF − Capex | $14.7M | $-157.1M |
| FCF MarginFCF / Revenue | 9.9% | -57.5% |
| Capex IntensityCapex / Revenue | 4.2% | 0.0% |
| Cash ConversionOCF / Net Profit | — | -10.19× |
| TTM Free Cash FlowTrailing 4 quarters | $30.9M | $93.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.8M | $-157.0M | ||
| Q3 25 | $2.2M | $256.3M | ||
| Q2 25 | $25.8M | $15.8M | ||
| Q1 25 | $14.4M | $-19.8M | ||
| Q4 24 | $29.8M | $-450.0M | ||
| Q3 24 | $17.7M | $119.2M | ||
| Q2 24 | $9.8M | $-61.7M | ||
| Q1 24 | $8.7M | $-59.2M |
| Q4 25 | $14.7M | $-157.1M | ||
| Q3 25 | $-5.7M | $255.6M | ||
| Q2 25 | $15.0M | $15.0M | ||
| Q1 25 | $7.0M | $-20.5M | ||
| Q4 24 | $22.0M | — | ||
| Q3 24 | $8.3M | $118.4M | ||
| Q2 24 | $1.3M | $-62.3M | ||
| Q1 24 | $428.0K | $-59.8M |
| Q4 25 | 9.9% | -57.5% | ||
| Q3 25 | -3.6% | 38.1% | ||
| Q2 25 | 10.4% | 3.8% | ||
| Q1 25 | 4.9% | -5.8% | ||
| Q4 24 | 15.0% | — | ||
| Q3 24 | 5.5% | 21.5% | ||
| Q2 24 | 0.9% | -19.6% | ||
| Q1 24 | 0.3% | -17.9% |
| Q4 25 | 4.2% | 0.0% | ||
| Q3 25 | 4.9% | 0.1% | ||
| Q2 25 | 7.5% | 0.2% | ||
| Q1 25 | 5.2% | 0.2% | ||
| Q4 24 | 5.3% | 0.0% | ||
| Q3 24 | 6.2% | 0.1% | ||
| Q2 24 | 5.9% | 0.2% | ||
| Q1 24 | 6.1% | 0.2% |
| Q4 25 | — | -10.19× | ||
| Q3 25 | 0.04× | 2.95× | ||
| Q2 25 | — | 0.48× | ||
| Q1 25 | — | -0.63× | ||
| Q4 24 | — | -27.27× | ||
| Q3 24 | — | 1.46× | ||
| Q2 24 | — | -1.59× | ||
| Q1 24 | — | -1.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
